Fusion-guided biopsy helped transform prostate cancer diagnosis and gave clinicians a more precise way to target MRI-identified lesions. Now image guidance is entering its next chapter — expanding beyond biopsy to shape how targeted, minimally invasive interventions are planned and guided.
Join radiology and urology leaders from Duke University Medical Center and Rush University Medical Center for a live discussion on what that shift means for prostate cancer programs. They’ll examine how imaging, fusion guidance and treatment planning connect across the full care pathway, and how health systems can prepare.
The conversation centers on a question more prostate cancer programs are beginning to face: how to link imaging and procedural workflows so lesion information, planning and documentation move cleanly between radiology and urology.
You’ll learn:
- How image guidance is evolving beyond biopsy across the prostate cancer care pathway
- Ways to strengthen radiology and urology collaboration, including the transfer of imaging and lesion information across specialties
- Clinical and workflow considerations for adding targeted, minimally invasive prostate interventions to an established program
- How image-guidance technologies support procedural planning, visualization, guidance and documentation